Indeed, reduction in AHO simultaneously downregulated Prox1 and Klf4 expression compared with control eyes (Park et al., 2014), proposing Prox1 as an accurate biosensor for SC functionality, which might be used for the early detection and prevention of glaucoma in humans. This evidence concerns the gene PROX1 and pseudohypoparathyroidism type 1A.